Initial assessment of tumor regrowth after vismodegib in advanced Basal cell carcinoma (Q37183367)

18 August 2017

Initial assessment of tumor regrowth after vismodegib in advanced Basal cell carcinoma (English)

1 reference

18 August 2017

Anne Lynn S Chang

1

1 reference

PMCID

3777384

18 August 2017

Anthony E Oro

series ordinal

2

1 reference

18 August 2017

1 November 2012

1 reference

18 August 2017

Archives of Dermatology

1 reference

18 August 2017

148

1 reference

18 August 2017

11

1 reference

18 August 2017

1324-1325

1 reference

Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777384

Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777384

Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777384

Inhibition of the hedgehog pathway in advanced basal-cell carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777384

Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3777384

10.1001/ARCHDERMATOL.2012.2354

14 September 2017

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

3777384